NCT00188721View on ClinicalTrials.gov

Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer.

CompletedOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

September 30, 2009

Conditions

Breast Cancer

Trial Locations (2)

M5G 2M9

Ontario Cancer Institute, Princess Maraget Hospital, Toronto

Ontario Cancer Institute, Princess Margaret Hospital, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER

NCT00188721 - Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer. | Biotech Hunter | Biotech Hunter